NVCR NovoCure Ltd

8-K Current Report

Filed: February 24, 2026

Health Care

Surgical & Medical Instruments & Apparatus

NovoCure Ltd (NVCR) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 7.01 · Regulation FD Disclosure

• CMS revoked NVCR's Medicare billing privileges retroactive to Dec 17, 2025 — cited as administrative re-validation process issue, not substantive disqualification
• Revocation fully rescinded Feb 24, 2026; billing privileges reinstated retroactively to Dec 17, 2025 — gap effectively closed

+2 more insights

Other NovoCure Ltd 8-K Filings

8-K Feb 26, 2026

Get deeper insights on NovoCure Ltd

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.